UBS Group
CGEN icon

UBS Group’s Compugen CGEN Stock Holding History

UBS Group’s Portfolio CGEN Stock Details CGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$653K Sell
306,708
-43,753
-12% -$84.9K ﹤0.01% 5877
2025
Q4 		$536K Buy
350,461
+53,862
+18% +$89.4K ﹤0.01% 6037
2025
Q3 		$436K Buy
296,599
+6,174
+2% +$9.18K ﹤0.01% 6198
2025
Q2 		$517K Sell
290,425
-131
-0% -$194 ﹤0.01% 5977
2025
Q1 		$424K Sell
290,556
-34,025
-10% -$66.4K ﹤0.01% 5980
2024
Q4 		$497K Buy
324,581
+88,010
+37% +$143K ﹤0.01% 5836
2024
Q3 		$428K Sell
236,571
-58,360
-20% -$107K ﹤0.01% 5341
2024
Q2 		$495K Sell
294,931
-21,369
-7% -$44.5K ﹤0.01% 5011
2024
Q1 		$816K Buy
316,300
+1,603
+0.5% +$3.73K ﹤0.01% 4763
2023
Q4 		$623K Buy
314,697
+35,443
+13% +$31K ﹤0.01% 4917
2023
Q3 		$260K Buy
279,254
+27,339
+11% +$30.1K ﹤0.01% 5180
2023
Q2 		$287K Sell
251,915
-74,953
-23% -$65.3K ﹤0.01% 5236
2023
Q1 		$229K Buy
326,868
+89,937
+38% +$74K ﹤0.01% 5282
2022
Q4 		$171K Sell
236,931
-67,799
-22% -$59.1K ﹤0.01% 5592
2022
Q3 		$200K Sell
304,730
-25,324
-8% -$35.8K ﹤0.01% 5077
2022
Q2 		$611K Sell
330,054
-78,983
-19% -$170K ﹤0.01% 4105
2022
Q1 		$1.32M Buy
409,037
+232,993
+132% +$787K ﹤0.01% 3834
2021
Q4 		$756K Buy
176,044
+8,970
+5% +$48.5K ﹤0.01% 4631
2021
Q3 		$997K Buy
167,074
+109,874
+192% +$736K ﹤0.01% 4199
2021
Q2 		$474K Sell
57,200
-19,488
-25% -$158K ﹤0.01% 4771
2021
Q1 		$659K Buy
76,688
+13,797
+22% +$153K ﹤0.01% 4644
2020
Q4 		$762K Sell
62,891
-10,054
-14% -$139K ﹤0.01% 4238
2020
Q3 		$1.19M Buy
72,945
+56,529
+344% +$926K ﹤0.01% 3519
2020
Q2 		$247K Buy
16,416
+9,099
+124% +$123K ﹤0.01% 4644
2020
Q1 		$54K Sell
7,317
-40,914
-85% -$321K ﹤0.01% 5770
2019
Q4 		$288K Sell
48,231
-14,211
-23% -$73.1K ﹤0.01% 5321
2019
Q3 		$264K Sell
62,442
-6,781
-10% -$25.4K ﹤0.01% 5035
2019
Q2 		$266K Sell
69,223
-22,361
-24% -$79.1K ﹤0.01% 4728
2019
Q1 		$379K Buy
91,584
+5,840
+7% +$20K ﹤0.01% 4229
2018
Q4 		$186K Sell
85,744
-106,493
-55% -$337K ﹤0.01% 5009
2018
Q3 		$740K Sell
192,237
-75,848
-28% -$265K ﹤0.01% 4111
2018
Q2 		$885K Sell
268,085
-47,981
-15% -$180K ﹤0.01% 3875
2018
Q1 		$1.41M Buy
316,066
+299,546
+1,813% +$1.01M ﹤0.01% 3421
2017
Q4 		$42K Sell
16,520
-36,838
-69% -$110K ﹤0.01% 5971
2017
Q3 		$203K Sell
53,358
-30,910
-37% -$107K ﹤0.01% 4833
2017
Q2 		$320K Buy
84,268
+62,884
+294% +$262K ﹤0.01% 4446
2017
Q1 		$92K Buy
21,384
+16,981
+386% +$78.4K ﹤0.01% 5118
2016
Q4 		$23K Buy
4,403
+3,403
+340% +$20.4K ﹤0.01% 6424
2016
Q3 		$6K Sell
1,000
-1,378
-58% -$9.33K ﹤0.01% 7041
2016
Q2 		$15K Hold
2,378
– – ﹤0.01% 6504
2016
Q1 		$13K Buy
2,378
+1,228
+107% +$6.41K ﹤0.01% 6488
2015
Q4 		$7K Sell
1,150
-30
-3% -$197 ﹤0.01% 7497
2015
Q3 		$6K Sell
1,180
-7,369
-86% -$43K ﹤0.01% 7587
2015
Q2 		$59K Buy
8,549
+2,885
+51% +$20.2K ﹤0.01% 5851
2015
Q1 		$40K Buy
5,664
+1,187
+27% +$9.71K ﹤0.01% 6256
2014
Q4 		$37K Buy
+4,477
New +$34.4K ﹤0.01% 6858

Other funds holding CGEN

SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return

UBS Group's CGEN Position: Q1 2026 in Review

UBS Group reduced its Compugen (CGEN) stake by 12% in Q1 2026, selling an estimated $84.9K and leaving 306,708 shares worth $653K. The position accounts for ﹤0.01% of the portfolio, ranked #5877.

UBS Group first reported a position in CGEN in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.41M in Q1 2018. 78 funds tracked by Wall St. Rank hold CGEN as of Q1 2026.

  • UBS Group held 306,708 shares of Compugen worth $653K as of Q1 2026.
  • UBS Group sold 43,753 Compugen shares in Q1 2026, an estimated $84.9K.
  • Compugen made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5877 holding.
  • UBS Group first reported a position in Compugen in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Compugen position peaked at $1.41M in Q1 2018.
  • 78 funds tracked by Wall St. Rank held Compugen as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.